Past Event2020 BIO CEO & Investor Conference

Now in its 22nd year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because BIO’s mission is to support industry-wide success, it presents a broad and unbiased view of investment opportunities.

  • Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.
  • The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.
  • Our therapeutic workshops feature MDs, CSOs and industry analysts discussing the latest information on pipeline innovation for breakthrough therapeutic topics in biopharma. Seasoned industry executives and analysts delve into timely and relevant business models, deal-making and investment trends on our business roundtables.
  • VIEW THE EVENT OVERVIEW
  • LEARN MORE
Share:
Novo Norodisk

Novo Norodisk

Southwest Labs

Southwest Labs

UPS

UPS

Curia Global

Curia Global

Aerotek

Aerotek

Emera

Emera

Amgen

Amgen

STC UTM

STC UTM

Arrowhead Center

Arrowhead Center

New Mexico Consortium

New Mexico Consortium

Bio

Bio

Burrell College of Osteopathic Medicine

Burrell College of Osteopathic Medicine

Bristol Myers Squibb

Bristol Myers Squibb

Sandia National Laboratories

Sandia National Laboratories

Colliers

Colliers